Page last updated: 2024-11-03

propiverine and Disease Models, Animal

propiverine has been researched along with Disease Models, Animal in 7 studies

propiverine: anticholinergic used for overactive bladder syndrome

Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.

Research Excerpts

ExcerptRelevanceReference
" Furthermore, NS-21 increased the bladder capacity without suppressing micturition pressure, suggesting that NS-21 may be a more effective therapeutic drug than propiverine, oxybutynin or flavoxate for the treatment of urinary frequency and urinary incontinence."3.69Effect of NS-21, an anticholinergic drug with calcium antagonistic activity, on lower urinary tract function in a rat model of urinary frequency. ( Hamada, K; Kimura, K; Kimura, Y; Sasaki, Y; Seto, T; Ukai, Y; Yamazaki, C; Yoshikuni, Y, 1997)
"Pelvic venous congestion (PC) is thought to be related to several diseases of the lower urinary tract (LUT)."1.48Pelvic venous congestion induces lower urinary tract dysfunction in rats. ( Ashitomi, K; Kadekawa, K; Nishijima, S; Noguchi, K; Sugaya, K; Ueda, T; Yamamoto, H, 2018)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's3 (42.86)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nishijima, S2
Sugaya, K2
Kadekawa, K2
Ashitomi, K2
Ueda, T2
Yamamoto, H2
Noguchi, K1
Yoshiyama, Y1
Kojima, A1
Itoh, K1
Uchiyama, T1
Arai, K1
Shimizu, I1
Kawashima, K1
Ishii, D1
Oka, M1
Yokoyama, O1
Miwa, Y1
Oyama, N1
Aoki, Y1
Ito, H1
Akino, H1
Sasaki, Y1
Hamada, K1
Yamazaki, C1
Seto, T1
Kimura, Y1
Ukai, Y1
Yoshikuni, Y1
Kimura, K1
Oka, T1
Nakano, K1
Kirimoto, T1
Matsuura, N1

Other Studies

7 other studies available for propiverine and Disease Models, Animal

ArticleYear
Mechanisms underlying the effects of propiverine on bladder activity in rats with pelvic venous congestion and urinary frequency.
    Biomedical research (Tokyo, Japan), 2019, Volume: 40, Issue:4

    Topics: Animals; Benzilates; Disease Models, Animal; Female; Gene Expression Regulation; Hyperemia; Inflamma

2019
Pelvic venous congestion induces lower urinary tract dysfunction in rats.
    Biomedical research (Tokyo, Japan), 2018, Volume: 39, Issue:6

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Adrenochrome; Animals; Benzilates; Deoxyguanosine; Disease Models, Anim

2018
Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model.
    Neurobiology of disease, 2012, Volume: 45, Issue:1

    Topics: Animals; Benzilates; Cholinergic Antagonists; Disease Models, Animal; Hippocampus; Inflammation; Mic

2012
Urodynamics in a rat neurogenic bladder model with a unilateral electrolytic lesion of the basal forebrain.
    BJU international, 2003, Volume: 91, Issue:9

    Topics: Animals; Benzilates; Brain Diseases; Cholinergic Antagonists; Disease Models, Animal; Fumarates; Mal

2003
Antimuscarinic drug inhibits detrusor overactivity induced by topical application of prostaglandin E2 to the urethra with a decrease in urethral pressure.
    The Journal of urology, 2007, Volume: 178, Issue:5

    Topics: Administration, Intravesical; Administration, Topical; Adrenergic alpha-Antagonists; Animals; Atropi

2007
Effect of NS-21, an anticholinergic drug with calcium antagonistic activity, on lower urinary tract function in a rat model of urinary frequency.
    International journal of urology : official journal of the Japanese Urological Association, 1997, Volume: 4, Issue:4

    Topics: Animals; Atropine; Benzilates; Calcium Channel Blockers; Denervation; Disease Models, Animal; Flavox

1997
Effects of antimuscarinic drugs on both urinary frequency and cognitive impairment in conscious, nonrestrained rats.
    Japanese journal of pharmacology, 2001, Volume: 87, Issue:1

    Topics: Administration, Oral; Animals; Basal Nucleus of Meynert; Benzilates; Cognition Disorders; Consciousn

2001